Synact Pharma: Comment on Latest News Flow
Research Note
2020-08-31
15:52
Redeye gives a brief comment on the Q2 report from Synact. We also comment on Friday’s news regarding the company’s collaboration in viral infections.
LS
Ludvig Svensson
Disclosures and disclaimers